Japan Tobacco To Submit NDA For Hyperphosphatemia Drug
This article was originally published in PharmAsia News
Executive Summary
Japan Tobacco plans to file a new drug application for JTT-751 (ferric citrate) for hyperphosphatemia in Japan by March 2013